Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Spectrum Stock Tumbles 6% As Cancer Drug Threatened
Spectrum Stock Tumbles 6% As Cancer Drug Threatened
Spectrum Stock Tumbles 6% As Cancer Drug Threatened
Submitted by
admin
on December 10, 2011 - 12:40pm
Source:
Investor's Business Daily
News Tags:
Spectrum
Fusilev
generics
Headline:
Spectrum Stock Tumbles 6% As Cancer Drug Threatened
Do Not Allow Advertisers to Use My Personal information
